A Chinese patent medicine's long-term efficacy on non-dialysis patients with CKD stages 3-5: a retrospective cohort study

• मुख्य लेखकों: Hui-Fen Chen (लेखक), Yu-Jie Lin (लेखक), Yan Han (लेखक), Xian-Long Zhang (लेखक), Ruo-Bing Wang (लेखक), Jun-Hui Chen (लेखक), Ying Pi (लेखक), Li-Zhe Fu (लेखक), Fang Tang (लेखक), Xi-Na Jie (लेखक), Xiao-Na Tang (लेखक), Xu-Sheng Liu (लेखक), Yi-Fan Wu (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

BackgroundChinese patent medicine is commonly used in China as an important treatment mechanism to thwart the progression of chronic kidney disease (CKD) stages 3-5, among which Niaoduqing granules are a representative Chinese patent medicine; however, its long-term efficacy on CKD prognosis remains...